Detecting early-warning signals of type 1 diabetes and its leading biomolecular networks by dynamical network biomarkers
暂无分享,去创建一个
Xing-Ming Zhao | Xiaoping Liu | Luonan Chen | Rui Liu | Xingming Zhao | Luonan Chen | Xiaoping Liu | Rui Liu
[1] I. Chang,et al. Death effectors of beta-cell apoptosis in type 1 diabetes. , 2004, Molecular genetics and metabolism.
[2] Xiang-Sun Zhang,et al. APG: an Active Protein-Gene Network Model to Quantify Regulatory Signals in Complex Biological Systems , 2013, Scientific Reports.
[3] H. Kikutani,et al. The murine autoimmune diabetes model: NOD and related strains. , 1992, Advances in immunology.
[4] C. Benoist,et al. Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes , 1999, The Journal of experimental medicine.
[5] Kazuyuki Aihara,et al. Identifying critical transitions and their leading biomolecular networks in complex diseases , 2012, Scientific Reports.
[6] Yan Zhang,et al. Research and applications: An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer , 2013, J. Am. Medical Informatics Assoc..
[7] N. Rose,et al. Type 1 diabetes: virus infection or autoimmune disease? , 2002, Nature Immunology.
[8] Luonan Chen,et al. Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. , 2012, Journal of molecular cell biology.
[9] I. Chang,et al. Death effectors of β-cell apoptosis in type 1 diabetes , 2004 .
[10] F. Lepault,et al. Pancreatic Lymph Nodes Are Required for Priming of β Cell Reactive T Cells in NOD Mice , 2002, The Journal of experimental medicine.
[11] M. Atkinson,et al. The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.
[12] Kazuyuki Aihara,et al. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers , 2012, Scientific Reports.
[13] Stephen T. C. Wong,et al. Cross-platform method for identifying candidate network biomarkers for prostate cancer. , 2009, IET systems biology.
[14] Mark S. Anderson,et al. The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.
[15] Bhagirath Singh,et al. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. , 1997, Immunity.
[16] Xing-Ming Zhao,et al. Identifying disease genes and module biomarkers by differential interactions , 2012, J. Am. Medical Informatics Assoc..
[17] S. Pervaiz,et al. Apoptosis in the pathophysiology of diabetes mellitus. , 2007, The international journal of biochemistry & cell biology.
[18] Atul J Butte,et al. Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. , 2008, Clinical immunology.
[19] Zhiping Liu,et al. Network-based analysis of complex diseases. , 2012, IET systems biology.
[20] Luonan Chen,et al. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer. , 2013, Cancer letters.
[21] R. Tisch,et al. Elevated NF-κB Activation in Nonobese Diabetic Mouse Dendritic Cells Results in Enhanced APC Function1 , 2002, The Journal of Immunology.
[22] Wen-Chi Chou,et al. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer , 2010, Nucleic acids research.
[23] Luonan Chen,et al. Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach , 2011, BMC Genomics.
[24] R. Flavell,et al. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. , 2002, Immunity.
[25] J. Piganelli,et al. Oxidative Stress and Redox Modulation Potential in Type 1 Diabetes , 2011, Clinical & developmental immunology.